Dr V Mohan, diabetologist and chairman of Madras Diabetes and Research Centre, told South First that about 50 companies are expected to release Indian generic versions of Semaglutide
Other health issues include anemia, cystic fibrosis, cancer, Alzheimers, Parkinsons, cataracts, glaucoma, aging, alcoholism, hepatitis, memory loss, AIDS, chronic fatigue syndrome, osteoarthritis, and infertility in men
Reduces Insulin Resistance: By improving the bodys response to insulin, Semaglutide helps decrease insulin resistance, a key factor in managing type 2 diabetes
The analogy sometimes used in the research literature: if endogenous GH release is like pressing both the accelerator (GHRH pathway) and releasing the brake (ghrelin pathway) simultaneously, the CJC/Ipamorelin combination approximates this dual-signal effect more closely than single-agent stimulation
Defying fears of losing significant market share to generics, innovators Novo Nordisk and Eli Lilly, along with their domestic partners Cipla, Emcure, and Abbott, have continued to show steady month-on-month growth, indicating a loyal prescriber base and patient onboarding
